Skip to content

Ali Salahpour

3 papers in the library · 72 citations · publishing 2016-2024

Papers

Sort Most recent Most cited

Cannabidiol, but Not Δ9-Tetrahydrocannabinol, Has Strain- and Genotype-Specific Effects in Models of Psychosis

Cannabis & Cannabinoid Research February 1, 2024 Catharine A. Mielnik, Chun Kit Li, Amy J. Ramsey et al.

Introduction: Cannabis use has been associated with an increased incidence of psychiatric disorders, yet the underlying neurobiological processes mediating these associations are poorly understood. Whereas exposure to Δ9-tetrahydrocannabinol (THC) has been associated with the development or exacerbation of psychosis, treatment with cannabidiol (CBD) has been associated with amelioration of...

Structure-Activity Relationships of Dopamine Transporter Pharmacological Chaperones.

Frontiers in Cellular Neuroscience 2022 Charles Sutton, Erin Q Williams, Hoomam Homsi et al. 13 citations

Mutations in the dopamine transporter gene (SLC6A3) have been implicated in many human diseases. Among these is the infantile parkinsonism-dystonia known as Dopamine Transporter Deficiency Syndrome (DTDS). Afflicted individuals have minimal to no functional dopamine transporter protein. This is primarily due to retention of misfolded disease-causing dopamine transporter variants. This results...

Pharmacological Chaperones of the Dopamine Transporter Rescue Dopamine Transporter Deficiency Syndrome Mutations in Heterologous Cells.

The Journal of biological chemistry October 14, 2016 Pieter Beerepoot, Vincent M Lam, Ali Salahpour 59 citations

A number of pathological conditions have been linked to mutations in the dopamine transporter gene, including hereditary dopamine transporter deficiency syndrome (DTDS). DTDS is a rare condition that is caused by autosomal recessive loss-of-function mutations in the dopamine transporter (DAT), which often affects transporter trafficking and folding. We examined the possibility of using...